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Abstract
Key pathological hallmarks of Alzheimer’s disease (AD), including amyloid plaques, cerebral amyloid angiopathy (CAA) and
neurofibrillary tangles do not completely account for cognitive impairment, therefore other factors such as cardiovascular
and cerebrovascular pathologies, may contribute to AD. In order to elucidate the microvascular changes that contribute to
aging and disease, direct neuropathological staining and immunohistochemistry, were used to quantify the structural
integrity of the microvasculature and its innervation in three oldest-old cohorts: 1) nonagenarians with AD and a high
amyloid plaque load; 2) nonagenarians with no dementia and a high amyloid plaque load; 3) nonagenarians without
dementia or amyloid plaques. In addition, a non-demented (ND) group (average age 71 years) with no amyloid plaques was
included for comparison. While gray matter thickness and overall brain mass were reduced in AD compared to ND control
groups, overall capillary density was not different. However, degenerated string capillaries were elevated in AD, potentially
suggesting greater microvascular ‘‘dysfunction’’ compared to ND groups. Intriguingly, apolipoprotein e4 carriers had
significantly higher string vessel counts relative to non-e4 carriers. Taken together, these data suggest a concomitant loss of
functional capillaries and brain volume in AD subjects. We also demonstrated a trend of decreasing vesicular acetylcholine
transporter staining, a marker of cortical cholinergic afferents that contribute to arteriolar vasoregulation, in AD compared
to ND control groups, suggesting impaired control of vasodilation in AD subjects. In addition, tyrosine hydroxylase, a marker
of noradrenergic vascular innervation, was reduced which may also contribute to a loss of control of vasoconstriction. The
data highlight the importance of the brain microcirculation in the pathogenesis and evolution of AD.
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Introduction
The number of elderly individuals with neurodegenerative
disorders such as Alzheimer’s disease (AD) has expanded
dramatically [1]. Alzheimer’s disease is an age-associated
multisystemic syndrome. Cardiovascular disease (CVD), the most
prevalent cause of morbidity and mortality [2], has long been
associated with vascular cognitive impairment (VCI) and
represents a potential contributing factor to AD development
[3–6]. Studies suggest that common cardiovascular-related
diseases such as hypertension [7,8], hypotension [9], atheroscle-
rosis [10], arteriosclerosis [11], stroke [12], coronary artery
disease [13] and diabetes [14] are risk factors for VCI and AD. In
addition, the major genetic risk factor for AD, possession of the
apolipoprotein E (ApoE) e4 allele [15,16], is also a recognized risk
factor for CVD [10,17]. Ultrasonography, imaging and bio-
chemical studies have demonstrated that individuals with AD
have diastolic dysfunction [18], decreased carotid diastolic
velocities [19], decreased mean flow velocities and increased
pulsatility indices [19], decreased total and regional cerebral
blood flow [20], reduced brain perfusion [21], disturbances of the
blood-brain barrier and neurovascular unit alterations [4,22].
Furthermore, a diminished cardiac output and cardiac index
have been associated with aging [23,24]. Cerebral amyloid
angiopathy (CAA) also plays a major role in brain hypoperfusion
and dysfunction. Brain perfusion is further damaged by CAA due
to a compromised interstitial fluid drainage resulting from the
destruction of the perivascular spaces by the accumulation of
amyloid [25]. Moreover, hypoperfusion promotes loss of blood
flow shear stress, resulting in endothelial cell death and collapse
of capillaries contributing to the formation of string vessels
[26,27]. In addition to all these pathological changes, cerebral
hypoperfusion also promotes vascular inflammation [4] and the
expression of hypoxia-inducible and pro-angiogenic factors [28].
The emergence of anti-angiogenic molecules, including Ab
peptides [29], may counterbalance activation of vascular remod-
eling and repair functions [4,30].
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interfere with cerebral perfusion, in AD there is impairment of
regional cerebral blood flow which is regulated by the neurovas-
cular units that respond to local biochemical demands [3,6,31–
33]. These regulatory mechanisms of cerebral blood flow are
deeply disturbed in AD, resulting in hypoperfusion as elegantly
demonstrated by arterial spin labeling [34,35]. In addition to this
regional autoregulation, the brain vasoactive centers are severely
injured in AD. Cholinergic projections from the nucleus basalis of
Meynert (NBM) extend into the cortex and are a major mediator
for vasodilation of cortical arterioles and capillaries. Stimulation of
the NBM activates muscarinic and nicotinic acetylcholine
receptors in perivascular neurons and astrocytes to release the
vasodilator nitric oxide [36–40]. Vasoconstriction is mediated in
part by catecholaminergic and serotonergic innervation emanating
from the locus ceruleus and dorsal raphe nucleus, respectively [41–
43].
Considering the cumulative consequences of CAA and com-
bined cardiovascular and cerebrovascular disease in AD, it would
be expected that non-demented (ND) control individuals have a
better conservation of brain microvasculature than those with AD.
The presence and abundance of amyloid plaques and CAA
increases with age, but not all individuals with high amyloid
plaque burdens and CAA develop cognitive impairment. An
explanation for this apparent contradiction may be that cognitively
normal individuals with high amyloid loads have better cerebro-
vascular preservation. In order to address these questions, some
structural aspects of the microvasculature and its innervation as
well as their relationships to brain atrophy were investigated in
oldest-old subjects with and without amyloid plaques and with and
without dementia. In addition, a ND cohort of younger individuals
without amyloid plaques was included for comparison. For the
final assessment of the morphological and pathological conditions
of the microvasculature among these groups, we combined the
available clinical and neuropathological data to generate an
overall brain fitness index (BFI) for each individual.
Materials and Methods
Human Subjects
Brain specimens were obtained from the Banner Sun Health
Research Institute Brain and Body Donation Program [44]. The
operations of the Brain and Body Donation Program, including
those related to this study, have been approved by the Banner
Health Institutional Review Board. All subjects enrolled in the
Brain and Body Donation Program sign an informed consent
approved by the Banner Health Institutional Review Board. All
AD subjects met NINCDS-ADRDA criteria for a clinical
diagnosis of probable and possible AD as previously published
[45]. Cases examined in this study were selected on the bases of
age and the guidelines established by the National Institute on
Aging (NIA)-Reagan Institute, to warrant classification as AD, and
were not complicated by other neuropathological diagnoses,
including Lewy body lesions. The study compared four neuro-
pathologically assessed cohorts (Table 1): 1) six nonagenarian
individuals diagnosed clinically as having AD (cases 10–15)
harboring sufficient AD amyloid plaque density to meet NIA-
Reagan criteria of ‘‘intermediate’’ or ‘‘high’’ probability that
dementia was due to AD; 2) eight nonagenarian individuals (cases
1–8) clinically assessed as ND with sufficient amyloid plaque
density to meet NIA-Reagan criteria of ‘‘intermediate’’ probability
that dementia, were it present, would be due to AD. These
individuals were classified as non-demented high pathology
controls (ND-HPC); 3) six nonagenarian individuals (cases 50–
55) clinically assessed as ND exhibiting total plaque scores of zero,
classified as oldest-old no plaque controls (OO-NPC) and 4) five
septuagenarian individuals (cases 60–64) clinically assessed as ND
and exhibiting total plaque scores of zero, classified as young-old
no plaque controls (YO-NPC). Other AD-related pathologies such
as neurofibrillary tangle (NFT) score, Braak stage, CAA, white
matter rarefaction (WMR) and ApoE genotype were not
considered in the selection of these cases. The complete
neuropathological and epidemiological data of the selected cases
are included in Table 1 and the Table S1.
Neuropathological Evaluation
The neuropathological examination procedures used in this
study were previously described in Maarouf et al. [46]. Amyloid
deposits, NFT and WMR were visualized by staining 40 mm
sections with Campbell-Switzer, Thioflavine-S, Gallyas and
hematoxylin and eosin (H&E). The clinicopathological diagnosis
of AD was established if cases had an NIA-Reagan rating of
‘‘intermediate’’ or higher, neuritic plaque density moderate or
frequent and Braak NFT stage III-VI [47] and were clinically
demented. Plaque densities (all plaque types, including diffuse,
neuritic and cored, were considered together) were reported
numerically as 0, 1, 2 and 3, for none, sparse, moderate and
frequent, respectively, using the CERAD templates [48,49]. Five
separate regions were appraised: frontal, temporal, parietal,
hippocampal and entorhinal, to render a maximum score of 15.
The total NFT score was ranked in the same fashion as described
for plaques, again using the published CERAD templates. The
Braak stage (I-VI) was estimated in thick sections according the
original method described by Braak and Braak [47]. White matter
rarefaction was evaluated on one-quarter of hemisphere sections
stained by H&E in the frontal, temporal, parietal and occipital
lobes. The evaluations were none, mild (less than 25% affected),
moderate (25–50% affected) and severe (greater than 50%
affected) and were converted into numeric scores of 0, 1, 2, 3,
yielding a maximum possible score of 12 [44]. The CAA score was
assessed in a similar fashion as none, mild, moderate and severe (0,
1, 2 and 3). The ApoE genotype was determined for each subject
using a modification of the technique of Hixson and Vernier [50]
as published previously [51].
Immunohistochemistry
Formalin-fixed brain specimens were sectioned at 40 mm using
a freezing stage microtome and stored at 220uCi na
cryopreservative solution (30% glycerol+30% ethylenegly-
col+20 mM phosphate buffer). All steps were performed at room
temperature with washes in PBSTX (phosphate-buffered saline
+0.3% Triton X-100) between each step unless otherwise
indicated. Free-floating sections were placed in 1% H2O2 in
PBSTX for 30 min and then blocked in 1% normal goat serum in
PBSTX for 1 h. Sections were incubated in monoclonal mouse
anti-human collagen IV primary antibody (Dako, Carpinteria,
CA, cat. # 0785, dilution=1:1000) in PBSTX +1% bovine serum
albumin+protease inhibitor cocktail (Roche) overnight, incubated
in biotinylated goat anti-mouse IgG (Vector Laboratories,
Burlingame, CA, dilution 1:1000) in PBSTX with 1% normal
goat serum for 2 h, followed by incubation in Strep-HRP
(Invitrogen, Carlsbad, CA, SNN1004, dilution 1:10,000) in
PBSTX for 2 h. Sections were washed with PBSTX and Tris
buffer (0.05 M Tris, pH 7.6) solutions. Staining was developed
with nickel-enhanced 3,39-diaminobenzidine for 30 min followed
by washing with Tris buffer and the sections mounted on slides
and dried. The slides were rehydrated in water, dehydrated by
passage through a graded concentration alcohol solution series,
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Thermo Fisher Scientific, Waltham, MA). For vesicular acetyl-
choline transporter (VAChT) staining, the rabbit polyclonal anti-
VAChT primary antibody (Phoenix Pharmaceuticals, Burlingame,
CA, cat. # H-V005, dilution 1:15,000) and a goat anti-rabbit-
HRP secondary antibody (Jackson ImmunoResearch Laborato-
ries, West Grove, PA) were used. For tyrosine hydroxylase (TH)
staining, a rabbit polyclonal anti-TH primary antibody was
employed (Millipore, Billerica, MA, cat. # AB152, dilution
1:2000) and a biotinylated goat anti-rabbit was used as a
secondary antibody (Vector Laboratories, cat. # BA-1000,
dilution 1:1000) followed by incubation with Strep-HRP as
described above.
Imaging Assessments
Collagen IV, VAChT and TH stained sections were imaged by
systematic random sampling on a 464 mm grid. Imaging was
performed with a Leica DMLB microscope using a Leica PLAN
APO 10X objective lens (Buffalo Grove, IL) and captured with a
Magnafire-SP camera (model s99805). Images from the entire
Table 1. Tabulation of the demographic, clinical and neuropathological parameters.
ID
Expired
age (y) Gender PMI (h)
Brain
weight
(g)
Last
MMSE
score
ApoE
genotype
Total
plaque
score
NP
density
Total NFT
score
Braak
stage
Total
WMR
score
Total CAA
score
10 95 F 3.2 1040 16 3/4 12.2 Freq. 10.0 VI (6) 0 8
11 90 M 14.0 1300 19 3/3 11.0 Mod. 6.3 IV (4) 7 2
12 96 F 3.0 1000 18 3/3 13.8 Mod. 8.0 IV (4) 1 6
13 96 F 3.0 900 5 2/3 10.0 Freq. 15.0 VI (6) 12 12
14 96 F 3.3 960 13 3/4 11.5 Freq. 15.0 VI (6) 10 9
15 92 F 2.8 900 13 4/4 14.5 Freq. 15.0 VI (6) 3 2
Mean 94.2 4.9 1017 14.0 12.2 11.5 5.33 5.5 6.5
ND-HPC
1 91 M 3.0 1050 - 3/4 10.8 Mod. 5.0 III (3) 0 0
2 100 M 2.5 1160 29 3/3 14.0 Mod. 8.0 IV (4) 1 8
3 90 F 4.3 975 28 3/3 10.5 Freq. 5.0 III (3) 1 0
4 94 M 3.5 1100 27 3/3 15.0 Freq. 10.5 IV (4) 10 9
5 90 F 2.5 966 25 3/3 13.5 Freq. 8.0 IV (4) 2 1
6 92 M 3.2 1300 27 2/4 14.0 Freq. 12.0 V (5) 1 8
7 91 M 4.3 1150 29 2/3 14.5 Mod. 8.5 IV (4) 1 1
8 94 M 2.5 1050 29 3/3 15.0 Freq. 12.0 IV (4) 2 1
Mean 92.8 3.2 1094 27.7 13.4 8.6 3.88 2.3 3.5
OO-NPC
50 91 F 5.0 1112 - 2/3 0.0 Zero 5.0 III (3) 2 0
51 91 M 2.0 1330 30 3/4 0.0 Zero 7.5 IV (4) 1 0
52 91 F 2.5 1100 30 2/3 0.0 Zero 6.5 IV (4) 1 0
53 91 F 7.3 1100 30 3/3 0.0 Zero 4.0 IV (4) 4 0
54 99 F 3.5 975 29 3/3 0.0 Zero 3.5 III (3) 5 0
55 92 M 2.7 1225 29 3/3 0.0 Zero 8.5 IV (4) 1 0
Mean 92.5 3.8 1140 29.6 0.0 5.8 3.67 2.3 0.0
YO-NPC
60 75 F 2.8 1110 29 3/4 0.0 Zero 5.0 III (3) 0 0
61 71 M 3.0 1300 26 3/3 0.0 Zero 0.0 I (1) 0 0
62 68 F 2.6 1140 29 3/3 0.0 Zero 3.5 III (3) 4 0
63 65 M 3.5 1400 - 3/3 0.0 Zero 1.0 I (1) 2 0
64 75 M 3.3 1262 - 3/3 0.0 Zero 0.5 I (1) 3 0
Mean 70.8 3.0 1242 28.0 0.0 2.0 1.80 1.8 0.0
Table 1 abbreviations and explanations. AD=Alzheimer’s disease; ND-HPC=non-demented high pathology control; OO-NPC=oldest-old no plaque control;
YO=young-old no plaque control; ID=Case identification number, y=years, PMI=post mortem interval, h=hours, Brain weight indicates the brain mass at autopsy,
g=grams, MMSE=mini mental state exam, ApoE=apolipoprotein E, NP=neuritic plaque, Freq.=frequent, Mod.=moderate, NFT=neurofibrillary tangle, WMR=white
matter rarefaction, CAA=cerebral amyloid angiopathy. String vessels indicates the average number of string vessels from numerous images, TH=tyrosine hydroxylase
and TH density indicates the average % area of numerous images of sections stained with an anti-TH antibody. VAChT=vesicular acetylcholine transporter and VAChT
vesicles indicates the average number of vesicles per image from numerous images of VAChT stained sections. Gray matter thickness is the distance in pixels from the
tissue edge to the nearest area of white matter. Capillary number represents the average number of capillary objects from numerous images of collagen IV stained
sections while capillary density represents the average % area covered by capillaries from the same images.
doi:10.1371/journal.pone.0036893.t001
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confined to either gray matter or white matter were analyzed.
Images were analyzed using the National Institutes of Health
image analysis software ImageJ (version 1.451: http://imagej.nih.
gov/ij/). Using the Threshold tool in ImageJ, stained objects were
selected and converted to image masks. To ensure that only
capillaries were analyzed in the collagen IV images, larger
diameter vessels were removed from the analysis manually. For
accurate visual determination of the threshold for capillary images,
the original images from collagen IV-stained sections were
separated into red, green and blue channels in grayscale and only
the red channel was analyzed as this yielded the best contrast
between staining and the background. Similarly, the contrast was
adjusted when analyzing VAChT images to visually select the
point where threshold accuracy selected VAChT particles. The
ImageJ Background Removal tool was used to reduce background
color variations in TH images to enable accurate threshold
selection. For capillary analysis, a total of 660 gray matter and 757
white matter field images were analyzed. For VAChT staining,
909 gray matter images were analyzed. For TH staining 710 gray
matter and 757 white matter images were analyzed. All imaging
and image analyses were done blinded.
Analysis of Gray Matter Thickness
Slide-mounted sections were stained with filtered 1% Sudan
black in 70% EtOH for 5 min then destained in 70% EtOH until
the best contrast was obtained between gray and white matter.
Slides were then coverslipped and scanned on a flatbed scanner.
Images were analyzed in ImageJ. Approximately 100 measure-
ments per case were made by using manual straight line
measurements by selecting the shortest distance between the outer
surface of the gray matter and the boundaries of the white matter
over the entire ribbon of gray matter of the section. Since sections
denote only a single plane, this may not represent a perpendicular
projection relative to the gray matter surface. Therefore, it was
assumed that the shortest distance corresponded to the most likely
perpendicular plane. Thus, the lowest 30% of measurements were
selected and averaged to estimate gray matter thickness for each
case. Although the shortest dimensions gave a better estimate of
gray matter thickness, inclusion of all measurements gave similar
results.
Statistical Analysis and BFI Calculation
Capillary density, brain mass and gray matter thickness, string
vessel number and vascular innervation area were analyzed by
one-way analysis of variance (ANOVA) and Tukey post hoc test,
when applicable. Unpaired, 2-tailed t-tests were used to compare
string vessel numbers in ApoE e4 carriers and ApoE e4 non-
carriers and to compare ApoE e3/3 individuals with and without
plaques. Calculations were performed using GraphPad Prism 5
software (La Jolla, CA).
The BFI was calculated by using several neuropathological
variables shown in Table 1 and Table S1 which included: brain
weight, gray matter thickness, total NFT score, gray matter
capillary number, gray matter capillary density, white matter
capillary number, white matter capillary density, string vessel
number, VAChT vesicle number, TH neurite density in gray
matter, TH neurite density in white matter, total WMR score and
total CAA score. All of these variables were converted into z-scores
based on the mean and standard deviation of all non-AD
individuals. The BFI represents the arithmetic mean of all the z-
scores for each individual. For variables in which greater values
indicate greater brain pathology (string vessels, total NFT score,
total WMR, total CAA) the z-score was multiplied by -1 in order
for the z-score to reflect the appropriate direction of effect. The z-
scores of the OO-NPC and YO-NPC groups were almost identical
and therefore combined into one NPC group to increase the
statistical power of the control groups. ANOVA was used to
discern group differences (AD vs. ND-HPC vs. NPC) on the BFI z-
score. Bonferroni adjustment was used to correct for multiple
group comparisons. The Kruskal-Wallis test was used to compare
the BFI z-scores when individuals were grouped according to
Braak stage (Group 1: #IV, Group 2: $V). Two-sample t-tests
were used to determine if the BFI z-score differed significantly
between males and females and also between ApoE e4 carriers and
non-carriers.
Results
In order to investigate the integrity of the microvasculature in
AD and ND control groups, brain sections were stained with
collagen IV (Figure 1A–D) and the total capillary density for
each case was determined (Figure 1E–F). The average gray
matter capillary density was highest in the AD group and lowest in
the YO-NPC group, although these differences did not attain a
level of statistical significance (Figure 1E). Results were similar in
the white matter in which all nonagenarian groups were nearly
identical, with the YO-NPC group having the lowest capillary
density (Figure 1F). While capillary density was not significantly
altered, total brain mass, determined at autopsy, was significantly
less in AD compared to ND control groups (Figure 2A).
Quantifying cortical thickness on Sudan black stained sections
revealed the gray matter in AD cases was 16% thinner than YO-
NPC cases (Figure 2B).
Blood flow shear stress is a critical factor for maintaining
vascular endothelial cell survival. Decreased blood flow and/or
occlusion by microemboli contribute to loss of shear stress,
endothelial cell death, collapse of capillaries and the formation of
string vessels (Figure 3A). Infrequent evidence of microembolism
(Figure 3B) and sporadic bundled capillaries (Figure 3C) as
well as occasional tortuous vessels of larger caliber (Figure 3D)
were also observed. On average, the AD gray matter had more
than double the number of string vessels found in OO-NPC and
YO-NPC groups while the ND-HPC group was intermediate
(Figure 4A). Intriguingly, when stratified according to ApoE
genotype alone, ApoE e4 carriers had significantly higher string
vessel counts relative to non-e4 carriers regardless of cognitive
status (Figure 4B). When stratifying only by the presence or
absence of amyloid plaques and including only ApoE e3/3
individuals, those with plaques had significantly higher string
vessel counts than those without plaques (Figure 4C).I ti s
important to note that string vessels were included in the capillary
density analysis while vessels larger than capillaries were excluded.
Brain sections were stained for VAChT (Figure 5A–B) and
TH (Figure 5C–E) in order to investigate whether or not loss of
cholinergic and noradrenergic innervations contribute to AD
pathology, respectively. Examples of the range of VAChT and TH
densities are depicted in Figures 5A–E. VAChT-positive vesicles
were quantified in the gray matter and a trend was found toward
reduced VAChT particle number in AD compared to ND control
groups (Figure 5F). However, the difference did not reach the
level of statistical significance due to high individual variability.
Three AD cases had virtually no VAChT and on the average, the
YO-NPC group had about twice as many VAChT-positive
vesicles than the AD group (Figure 5F). Decreased TH staining
was found in grey matter and white matter in AD cases compared
to ND control cases although these differences did not reach
statistical significance (Figure 5G and 5H, respectively). In the
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36893Figure 1. Capillary density in gray matter and white matter. Sections from all cases were stained with collagen IV. A) Gray matter image from
an AD case. B) Gray matter image from a YO-NPC case. C) White matter image from an ND-HPC case. D) White matter image from an OO-NPC case. E-
F) Capillary density was determined by image analysis using ImageJ software as described in the Materials and Methods section. Each data point
represents the average % area covered by capillaries in numerous images from a single case. Bars represent the average of all cases and error bars
represent the SEM for all cases in a group. E) Gray matter capillary density. F) White matter capillary density. Groups were not significantly different as
determined by One-way ANOVA. The scale bar is applicable to all images in Figure 1.
doi:10.1371/journal.pone.0036893.g001
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reactivity in the grey matter and three that had similar levels of
staining as the ND controls (Figure 5G). Assessment of the TH-
positive neurites in the white matter also yielded similar results
(Figure 5H). Importantly, the levels of TH and VAChT staining
were positively correlated (correlation coefficient 0.732).
A statistical analysis was performed by combining the neuro-
pathological findings (see Table 1 and Table S1) from each case
to calculate the BFI. The individual BFI z-scores for all study
participants are displayed in Figure 6. The NPC group had
higher BFI z-scores and lower variability among their scores than
the other two groups. However, there was some degree of overlap
on the BFI z-scores between groups. Overall, there was a
statistically significant effect for the BFI (F=7.21, df=(2,22),
p=0.004). Bonferroni adjustment found that the AD and NPC
groups were significantly different from each other (p=0.003), but
the difference between AD and ND-HPC groups fell just short of
significance (p=0.06) for the BFI z-score. The ND-HPC and NPC
groups were not significantly different (p=0.73) from each other.
An additional analysis comparing the BFI z-scores by Braak stage
was also carried out. Individuals were classified into two groups
based on those who were at or below Braak Stage IV (n=20) and
those who were above Braak stage V (n=5). Due to the imbalance
in group sizes, the non-parametric Kruskal-Wallis test was carried
out and found that the lower Braak stage group had significantly
higher BFI z-scores than the higher Braak stage group (Kruskall-
Wallis=7.76, p=0.005). A separate ANOVA was carried out to
compare the string vessel count between groups. It was found that
only the AD and NPC groups were significantly different from
each other after adjusting for multiple comparisons (F=8.19,
(df=2,22), p=0.002). The ND-HPC group was not significantly
different from either the AD or NPC groups. Among the entire
study sample, there was no significant difference on the BFI z-
score between males and females (t=20.67, df=23, p=0.53). In
addition, there was no significant difference between ApoE e4
carriers and non-carriers (t=1.07, df=23, p=0.30).
Discussion
Our observations revealed that, in the oldest-old, the overall
capillary density in AD gray matter and white matter was not
significantly decreased compared to the ND control groups. It is
possible that since the capillary density relative to brain volume is
approximately the same among the groups, the rate of capillary
loss could have advanced at similar rates. In fact, we are faced with
a dilemma in which we do not know if capillary loss was
responsible for brain volume loss, or if brain volume loss led to
capillary demise or if both brain atrophy and capillary paucity
proceeded at the same time. Although controversial, the majority
of the morphometric studies report a decrease in vascular density
in AD as reviewed by Brown et al. [26]. Brown’s observations also
show that in the deep white matter in younger AD cases, the
density of microvessels is lower than controls. However, vascular
density decreases with age in normal controls as well, and
converges with the AD cases by the 9th decade of life [52].
Variations in age, disease stage, brain region and methodology
for quantifying vascular density could also explain the diversity of
results among the different studies. However, similarity in
microvascular density does not necessarily translate into functional
equality. For example, there is significant physical evidence for
decreased cerebral perfusion in AD using MRI imaging and
ultrasound technologies [19,34,53,54]. These hemodynamic ob-
servations strongly support the contention that in AD there is
diffuse microvascular disease.
While capillary density was not significantly decreased, there
was an overall brain atrophy and thinning of cortical grey matter
in AD compared to ND control groups. Grey matter thickness was
slightly reduced in OO-NPC relative to ND-HPC although not
significantly, but was clearly decreased in AD cases. This may
indicate that the grey matter cannot be reduced too severely
without resulting in cognitive decline and moving into the AD
category.
Decreased cerebral blood flow along with the findings of similar
capillary densities in the current study, may be explained by the
presence of string vessels. String vessels may form as a result of
endothelial cell death followed by collapse of the capillary walls,
leaving only remnants of the extracellular matrix in the form of a
thin string. It is thought that shear stress caused by blood flow is
required for vascular endothelial cell survival and continued vessel
patency. Loss of shear stress can be caused by at least two
mechanisms; loss of blood flow or vascular blockage by
microemboli that are not extravasated [26,27,55,56]. While some
string vessels were likely the result of blockage by microemboli,
Figure 2. Brain mass and gray matter thickness. A) Total brain mass was determined at the time of autopsy for each case. B) Gray matter
thickness for each case was determined by numerous straight-line measurements of the gray matter ribbon on sections from each case. Represented
in each data point is the average of the lowest 30% of measurements for each case. In graphs A and B, bars represent the average for all cases in the
group and error bars represent the SEM. Statistical analysis: One-way ANOVA was performed for brain mass (p=0.047) and for gray matter thickness
(p=0.0012). A Tukey post test was performed for pair-wise comparison of all groups and significance is indicated on the graphs.
doi:10.1371/journal.pone.0036893.g002
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flow as the more typical cause of string vessel formation.
The number of string vessels in the YO-NPC group was
virtually identical to the OO-NPC group, thereby distinguishing
these groups from the AD group. The average number of string
Figure 3. Blood vessel abnormalities in the oldest-old. A) An
area of high string vessel density in an AD case. String vessels are
indicated by arrows. B) A string vessel exhibiting a microembolus
(arrow) in an AD case. C) Abnormally bundled capillaries in an AD case.
D) A large tortuous vessel in the white matter of an AD case. All sections
were stained for collagen IV.
doi:10.1371/journal.pone.0036893.g003
Figure 4. Distribution of string vessels in the four studied
groups. A) The number of string vessels was determined by counting
string vessels in collagen IV-stained sections. Each data point represents
the average number of string vessels per field for numerous images for
each case. Bars represent the average of all cases in a group and error
bars represent the SEM. Statistical analysis: One-way ANOVA revealed
statistically increased string vessel numbers in AD compared to ND
control groups; p=0.0076, with a Tukey post test indicating statistical
increase in AD compared to OO-NPC and YO-NPC groups. B) String
vessel number stratified according to ApoE e4 carrier status. Statistical
analysis: t-test reveals a significant increase in string vessels in ApoE e4
carriers (p=0.0044). C) String vessel number of ApoE e3/3 individuals
with or without amyloid plaques. Statistical analysis: t-test reveals a
significant increase in string vessel number in cases with amyloid
plaques (p=0.0027).
doi:10.1371/journal.pone.0036893.g004
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36893Figure 5. Vascular innervation of the oldest-old. A-B) The amount of innervation of the cortex by cholinergic neurons was determined by
staining with VAChT. A) An example of low VAChT staining in an AD case. B) An example of high VAChT staining in a YO-NPC case. C-D) The amount
of innervation of the cortex by noradrenergic neurons was determined by staining with TH. C) An example of low TH staining in AD case. D) An
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higher than the NPC groups demonstrating an intermediate, but
clear, disruption of the microvasculature. The fact that ND
individuals survived into the 9
th decade of life suggests a better
‘‘cognitive reserve’’ or microvasculature quality, which may result
in enhanced brain perfusion. The data support the need for
understanding the processes that control microvascular density,
capillary loss, angiogenesis [57] and string vessel genesis [27], all in
the context of atrophic grey and white matter [58]. All of these
observations support the hypothesis of decreased perfusion in AD
and could explain the increased number of string vessels observed
in this study. While it has been reported that string vessel numbers
are elevated in AD [26,59], no study has focused on AD cases of
such advanced age and on the unique ND control groups used in
this study.
The presence of ApoE e4 correlates with string vessel number.
Likewise, the numbers of string vessels also appeared to be
associated independently with the number of amyloid plaques.
Unfortunately, ApoE status and amyloid load could not be tested
together as predictors of string vessel numbers, since we have a
small sample size and total amyloid plaque score was used as
sample selection criteria. It has been hypothesized that amyloid
plaques form as a result of capillary leakage and that plaques may
eventually cut off blood flow leaving blind capillary stumps [60–
62]. In addition, Ab has been shown to have anti-angiogenic
properties [63,64]. In light of recent findings of increased
angiogenesis in AD, Ab may be released to control aberrant
angiogenesis [65]. In exudative macular degeneration, vascular
endothelial growth factor (VEGF) expression, induced by hypoxia,
drives anomalous angiogenesis and these new vessels leak resulting
in the formation of Ab-positive plaques. This explanatory chain of
events was recently reinforced by the effectiveness of anti-Ab
antibodies in the treating macular degeneration [66,67].
The physical nature and rapid development of individual
amyloid plaques [68] suggests a swift response to a focal insult such
as a leaky capillary, or CAA formation around larger vessels whose
permeability may be compromised. While it is tempting to think
that string vessels follow occlusion by compact amyloid plaque
cores, this may not be the case. It is feasible that two independent
mechanisms could be in play. For instance, reduced perfusion and
the resultant hypoxia could induce angiogenesis and formation of
amyloid plaques at the site of new leaky capillaries, while
simultaneously, loss of blood flow and shear stress would result
in the formation of string vessels at different loci. Additional
studies regarding the relationship between string vessels and
amyloid plaques are warranted.
One mechanism of regulating regional cerebral blood flow is by
neuronal modulation of vasodilatation and vasoconstriction.
Cholinergic afferents from the NBM project to the cerebral cortex
to regulate vasodilation mediated by a nitric oxide synthase
response. Vasoconstriction is in part regulated by the noradren-
ergic locus ceruleus (LC) [41]. In AD, one of the nuclei first
affected in the course of this dementia is the NBM [69] and
examination of both NBM and LC in AD revealed a marked
depletion of neurons [70,71]. While not statistically significant, we
found that on average, AD cases had less innervation as
determined by VAChT and TH immunohistochemistry, suggest-
ing that this depletion may contribute to the vascular lesions
demonstrated in this paper. Ablation of the nucleus basalis
magnocellularis in the rabbit (corresponding to NBM in humans)
results in the deposition of perivascular Ab in cortical microvessels
demonstrating a critical link between Ab pathology and the
neurovascular unit [38]. Interestingly, loss of VAChT innervation
also correlated well with loss of TH staining, but not other
dysfunctional parameters, suggesting that these two markers are
mechanistically independent from other pathologies.
To better estimate the overall brain health of the individuals in
our study, we created a BFI-z score. This index revealed that the
NPC cohorts in our study had the best BFI-z scores and served as a
frame of ‘healthy’ reference, while AD cases had many deleterious
contributing factors. On the average, the ND-HPC group had an
intermediate BFI suggesting that they may have had prodromal
AD or other compensatory mechanisms that protected them from
dementia. While many of the parameters in our BFI were
determined postmortem, similar multifaceted approaches are
beginning to be adopted using many biomarkers from imaging,
CSF, plasma and other physical measurements in the living to
better estimate the risk of dementia and rate of decline [72]. The
ApoE e4 risk was not a significant contributing factor to the BFI in
our study and thus was not included in the BFI calculation. This is
likely due to several factors such as small sample size or to the
decreasing ApoE e4 risk factor effect with advancing age [73].
Taken together the data suggest that while a high amyloid plaque
example of high TH staining in a YO-NPC case gray matter. E) White matter TH staining in an OO-NPC. F) Cholinergic innervation of cortical gray
matter was quantified by counting the number of VAChT-positive vesicles per field using ImageJ software as described in the Materials and Methods
section. Each point represents the average number of vesicles observed in each case. G) Noradrenergic innervation of cortical gray matter, as
determined by TH staining, was quantified by determining the % area stained in each image. Each point represents the average % area observed in
each case. H) The TH immunoreactivity in cortical white matter was quantified as in the gray matter. For all graphs, bars represent the average of all
cases for each group with their SEM. Groups were not significantly different by One-way ANOVA. Magnification: A and B=200X; C, D and E=100X.
doi:10.1371/journal.pone.0036893.g005
Figure 6. Brain fitness index. The overall brain fitness of each
individual was determined by statistical analysis of 13 parameters
described in Materials and Methods section and shown in Table 1 and
Table S1. The BFI represents the mathematical average of all the z-
scores for each individual. Bars represent the average of all cases for
each group with error bars representing the SEM. Statistical analysis:
One-way ANOVA demonstrated statistical difference (F=7.21 df=(2,
22), p=0.004). Bonferroni adjustment found that the AD and ND-HPC
groups were not significantly different (p=0.06) and that the AD and
NPC groups were significantly different (p=0.003). The ND-HPC and
NPC groups were not significantly different (p=0.73). Both AD and ND-
HPC had a negative BFI relative to the NPC group, being more negative
in the AD group.
doi:10.1371/journal.pone.0036893.g006
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cognitive status and brain fitness depend on many other factors.
In summary, our data reveal microvascular morphological
alterations and loss of vascular innervation, supporting the
hypothesis that hemodynamic changes may contribute to VCI
and dementia. Further, in spite of high amyloid plaque numbers,
some nonagenarian individuals survive without dementia elimi-
nating these lesions as the sole factor in AD pathogenesis. In the
end, it remains unclear whether a decrease in brain perfusion is
responsible for neurodegeneration or if the primary loss of
neurons, neurites and synapses is accountable for poor brain
perfusion or both. Nevertheless, we suggest that multiple,
concurrent cardiovascular and cerebrovascular pathological fac-
tors decrease blood flow. Consequential brain hypoperfusion
results in neurovascular unit functional impairment and micro-
vascular demise (Figure 7). Neurons in proximity to string vessels
and amyloid plaques eventually perish due to localized hypoxia/
oligemia, thus contributing to the cognitive deficits seen in AD.
Lifestyle changes and timely pharmacological interventions that
promote vascular health and enhance perfusion may therefore be
beneficial in preventing or slowing the progression of AD.
Supporting Information
Table S1 Abbreviations and explanations. AD=Alzhei-
mer’s disease; ND-HPC=non-demented high pathology control;
OO-NPC=oldest-old no plaque control; YO=young-old no
plaque control; ID=Case identification number, y=years. String
vessels indicates the average number of string vessels from
numerous images, TH=tyrosine hydroxylase and TH density
indicates the average % area of numerous images of sections
stained with an anti-TH antibody. VAChT=vesicular acetylcho-
line transporter and VAChT vesicles indicates the average number
of vesicles per image from numerous images of VAChT stained
sections. Gray matter thickness is the distance in pixels from the
tissue edge to the nearest area of white matter. Capillary number
represents the average number of capillary objects from numerous
images of collagen IV stained sections while capillary density
represents the average % area covered by capillaries from the
same images.
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